Decoy Therapeutics earnings were -$13.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest DCOY earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.2M, down 75.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DCOY reported annual earnings of -$12.5M, with 124.5% growth. The next DCOY earnings date is Aug 11, 2026.
What were Decoy Therapeutics's earnings last quarter?
Decoy Therapeutics (NASDAQ: DCOY) reported Q1 2026 earnings per share (EPS) of -$4.18, up 98.26% year over year. Total DCOY earnings for the quarter were -$2.22 million. In the same quarter last year, Decoy Therapeutics's earnings per share (EPS) was -$240.07.
The next DCOY earnings call is Aug 11, 2026. Add DCOY to your watchlist to be reminded of Decoy Therapeutics's next earnings date.
What was DCOY's earnings growth in the past year?
As of Decoy Therapeutics's earnings date in Q3 2026, Decoy Therapeutics's earnings has grown year over year. DCOY earnings in the past year totalled -$13.03 million.
Is Decoy Therapeutics profitable or losing money?
As of the last Decoy Therapeutics earnings report, Decoy Therapeutics is currently losing money. Decoy Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$13.03 million, a 134% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.